View in EDS HTML Full Text PDF Full Text

Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.
Authors: Hirasawa Y; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Isobe J; Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan., Hosonuma M; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Tsurui T; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Baba Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Hematology, Showa Medical University Fujigaoka Hospital, Kanagawa, Japan., Funayama E; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University School of Pharmacy, Tokyo, Japan., Tajima K; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Murayama M; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan., Narikawa Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Kanagawa, Japan., Toyoda H; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Orthopedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan., Shida M; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Sasaki A; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Maruyama Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan., Amari Y; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Kanagawa, Japan.; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan., Mura E; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Suzuki R; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Iriguchi N; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Ishiguro T; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Ohkuma R; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Shimokawa M; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Ariizumi H; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Kubota Y; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Horiike A; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Sambe T; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Uchida N; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan., Wada S; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Kiuchi Y; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Kuramasu A; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Yoshimura K; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.; Department of Clinical Immuno-Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.
Source: Frontiers in immunology [Front Immunol] 2025 May 22; Vol. 16, pp. 1528521. Date of Electronic Publication: 2025 May 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1528521